Peptides DB

Research-centric peptide and protocol reference hub

Humanin vs Thymosin Alpha-1

Updated July 23, 2026 · Reviewed by the PeptidesDB Editorial team

Humanin: Research use — not FDA-approvedThymosin Alpha-1: Research use — not FDA-approved

A data-driven comparison of Humanin and Thymosin Alpha-1 (also searched as Thymosin Alpha-1 vs Humanin) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.

Verdict

Humanin centers on metabolic, while Thymosin Alpha-1 leans toward healing. On indexed research, Humanin is ahead (Humanin: 5 studies, Preclinical; Thymosin Alpha-1: 5, Human clinical). Choose by goal — and read the primary studies. This is research information, not medical advice.

Key takeaways

  • Humanin is strongest for metabolic; Thymosin Alpha-1 for healing.
  • Evidence: Humanin Preclinical (5 studies) vs Thymosin Alpha-1 Human clinical (5).
  • Both are research-use compounds — not FDA-approved.

Effect profiles, overlaid

HealingMuscleMetabolicNeuroSleepInflammationSkin
HumaninThymosin Alpha-1

At a glance

HumaninPreclinical

Mitochondria-Derived Peptide | HN

Strongest: MetabolicStudies: 5Level: Moderate Research
Thymosin Alpha-1Human clinical

Synthetic Thymic Hormone | Immune System Modulator

Strongest: HealingStudies: 5Level: Well Studied

Humanin vs Thymosin Alpha-1: side-by-side

MetricHumaninThymosin Alpha-1
ClassLongevityImmune
Regulatory statusResearch use onlyResearch use only
Evidence gradePreclinicalHuman clinical
Studies indexed55
Research levelModerate ResearchWell Studied
Strongest effectMetabolic & appetiteHealing & recovery
Healing & recovery0.34.0
Muscle & body comp0.70.0
Metabolic & appetite1.70.0
Neuro & mood1.70.0
Sleep & circadian1.30.0
Inflammation & immune1.34.0
Skin & aesthetics0.00.0

▲ marks the higher community effect score (0–5 perceived-effect signal, not clinical efficacy).

Mechanism & pharmacokinetics

PropertyHumaninThymosin Alpha-1
MechanismEnhances T-cell function and promotes maturation of immune cells

Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.

What is Humanin?

Mitochondria-associated peptide explored for longevity, metabolic, and organ-protective effects.

Full Humanin profile, mechanism & studies →

What is Thymosin Alpha-1?

### Thymosin Alpha-1 Summary Thymosin Alpha-1 (Tα1) is a peptide that plays a crucial role in modulating immune responses and has been investigated for its potential therapeutic applications in various conditions, including infections and inflammatory diseases.

Full Thymosin Alpha-1 profile, mechanism & studies →

Which is better for your goal?

GoalBetter fitWhy
HealingThymosin Alpha-14.0/5 effect signal
MuscleHumanin0.7/5 effect signal
MetabolicHumanin1.7/5 effect signal
NeuroHumanin1.7/5 effect signal
SleepHumanin1.3/5 effect signal
InflammationThymosin Alpha-14.0/5 effect signal

Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.

Can you stack Humanin and Thymosin Alpha-1?

People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.

Humanin vs Thymosin Alpha-1: side effects

Humanin

No community-reported effects logged yet.

Thymosin Alpha-1

No community-reported effects logged yet.

Anonymous community reports (count = number of reports), not clinical incidence rates.

What the research says

Humanin has 5 approved studies indexed (Preclinical), and Thymosin Alpha-1 has 5 (Human clinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.

Frequently asked questions

Is Humanin or Thymosin Alpha-1 better?

It depends on your goal. Humanin is strongest for metabolic; Thymosin Alpha-1 for healing. Humanin has more indexed studies (5). See the goal-by-goal breakdown above.

Is Humanin or Thymosin Alpha-1 better for weight loss?

Humanin shows the stronger metabolic & appetite profile (1.7/5) in community effect data — though weight-loss outcomes depend on the individual and the evidence base.

Is Humanin or Thymosin Alpha-1 better for muscle?

Humanin leads on the muscle & body-composition axis (0.7/5).

Which has more research, Humanin or Thymosin Alpha-1?

Humanin has 5 approved studies indexed (Preclinical); Thymosin Alpha-1 has 5 (Human clinical). Higher counts mean more to read, not proven superiority.

Can you stack Humanin and Thymosin Alpha-1?

Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.

What are the side effects of Humanin vs Thymosin Alpha-1?

Humanin: no community-reported effects logged yet. Thymosin Alpha-1: none logged yet. These are anonymous reports, not incidence rates — see each profile.

Is Humanin or Thymosin Alpha-1 FDA-approved?

Humanin is a research-use compound and is not FDA-approved. Thymosin Alpha-1 is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.

Is Thymosin Alpha-1 better than Humanin?

For healing, Thymosin Alpha-1 has the edge; for metabolic, Humanin does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.

Comparing related peptides

Regulatory & legal status

Humanin and Thymosin Alpha-1 are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 23, 2026.